All data are based on the daily closing price as of November 13, 2026
p
PharmaEngine
4162.TWO
1.66 USD
0.05
+3.11%
Overview
Last close
1.66 usd
Market cap
238.30M usd
52 week high
3.08 usd
52 week low
1.59 usd
Target price
3.65 usd
Valuation
P/E
14.1192
Forward P/E
6.2735
Price/Sales
7.639
Price/Book Value
1.551
Enterprise Value
78.50M usd
EV/Revenue
2.518
EV/EBITDA
3.9244
Key financials
Revenue TTM
31.18M usd
Gross Profit TTM
29.26M usd
EBITDA TTM
14.81M usd
Earnings per Share
0.12 usd
Dividend
N/A usd
Total assets
170.54M usd
Net debt
N/A usd
About
PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan. It offers ONIVYDE, a cancer medicine that blocks an enzyme called topoisomerase I, which is involved in copying cell DNA needed to make new cells. The company is also developing PEP07, a CHK1 inhibitor, which is in Phase 1 clinical trial for the treatment of hematological tumors and solid tumors. PharmaEngine, Inc. was incorporated in 2002 and is headquartered in Taipei, Taiwan.